Saturday 17 October 2026
Export QTRX’s income statement to Excel — free account
Quanterix Corporation
QTRX Healthcare Medical Devices
Quanterix Corporation’s revenue for fiscal 2025 (year ended December 2025) was $138.9 million, up 1.07% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS fell 35.1% and free cash flow grew 18.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
2.87
0.20
−6.51%
Follow QTRX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 5 | 3 | 4 | 4 | 5 | 4 | 4 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(0.87) | 2.44 | 7.33 | 3.18 | 15.10 | 12.17 | 7.16 | 5.21 | (0.11) | — |
P/S ratio |
1.95 | 2.97 | 8.34 | 4.51 | 13.81 | 15.93 | 10.45 | 10.70 | 6.61 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.83) | 5.08 | 5.92 | 5.62 | 10.29 | 3.92 | 1.83 | (5.98) | 0.61 | (9.15) |
P/Operating CF |
(16.49) | (94.80) | (164.84) | (107.41) | (152.54) | 295.64 | (130.74) | (49.67) | (34.39) | (5.78) |
Beneish M-Score |
(0.69) | (2.35) | (2.59) | (2.99) | (2.31) | (2.18) | (1.76) | 1.38 | (2.44) | (2.59) |
P/B ratio |
0.92 | 1.24 | 2.92 | 1.33 | 3.46 | 6.68 | 4.61 | 9.81 | 2.30 | 0.00 |
Price to Tangible BV |
1.97 | 1.25 | 2.97 | 1.36 | 3.63 | 7.56 | 5.65 | 10.77 | 2.30 | 0.00 |
EV/Sales |
1.12 | 1.16 | 6.04 | 1.71 | 10.42 | 14.17 | 8.66 | 9.93 | 3.54 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(2.01) | (4.52) | (39.24) | (3.71) | (24.20) | (52.38) | (18.77) | (13.00) | (3.66) | (0.67) |
EV/FCF |
(1.95) | (4.13) | (32.60) | (2.99) | (18.80) | (44.84) | (13.27) | (12.36) | (3.48) | (0.65) |
Quick Ratio |
1.98 | 7.65 | 8.89 | 11.41 | 11.37 | 4.99 | 6.05 | 2.83 | 4.33 | 3.07 |
Current Ratio |
2.84 | 8.66 | 9.80 | 12.17 | 12.14 | 5.52 | 6.69 | 3.28 | 4.53 | 3.22 |
Net Debt/EBITDA |
1.16 | 6.26 | 8.38 | 3.43 | 7.75 | 6.61 | 2.67 | 1.22 | 2.75 | 0.91 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.83% | 4.51% | 11.27% | 10.22% | 27.60% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.06 | 0.19 | 0.14 | 0.76 |
Asset Turnover |
0.34 | 0.33 | 0.28 | 0.23 | 0.29 | 0.39 | 0.48 | 0.47 | 0.35 | 0.79 |
Operating CF/Net income |
0.72 | 0.91 | 0.66 | 0.49 | 0.86 | 0.74 | 0.64 | 0.91 | 0.71 | 0.64 |
Capex/Depreciation |
(0.11) | (0.52) | (0.50) | (2.15) | (2.54) | (0.74) | (3.00) | (1.11) | (2.35) | (1.18) |
Interest Coverage |
— | — | 2.90 | 20.32 | (140.25) | (115.69) | 66.35 | 685.87 | (27.34) | (16.73) |
| (34.25%) | (11.33%) | (8.01%) | (24.93%) | (17.17%) | (18.84%) | (48.07%) | (58.98%) | 126.67% | 27.11% | |
| (25.97%) | (9.23%) | (6.58%) | (21.30%) | (14.38%) | (14.30%) | (34.35%) | (39.57%) | (48.39%) | (124.22%) | |
ROIC |
(44.21%) | (80.37%) | (100.39%) | (339.54%) | (79.41%) | (61.28%) | (95.71%) | (462.99%) | 0.00% | 0.00% |
Return on Tangible Assets |
(66.48%) | (11.37%) | (7.85%) | (26.91%) | (12.92%) | (16.28%) | (32.67%) | (71.20%) | (43.67%) | (108.26%) |
Average Days of Receivables |
78.76 | 85.37 | 75.81 | 65.78 | 78.53 | 72.61 | 70.16 | 65.88 | 89.34 | 81.30 |
Research and Development Expense of Revenue |
25.86% | 22.62% | 21.30% | 25.41% | 25.67% | 23.36% | 28.54% | 42.00% | 71.28% | 96.63% |
Selling, General and Administrative Expense of Revenue |
99.36% | 73.95% | 72.82% | 87.04% | 84.04% | 68.99% | 92.09% | 89.53% | 86.07% | 70.89% |
Intangible Assets out of Total Assets |
0.38 | 0.01 | 0.01 | 0.02 | 0.04 | 0.09 | 0.14 | 0.05 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
14.92% | 14.54% | 13.75% | 14.58% | 14.45% | 11.69% | 11.26% | 12.98% | 9.48% | 5.28% |
Graham Net Nets |
0.33 | 0.70 | 0.30 | 0.64 | 0.25 | 0.11 | 0.15 | 0.08 | 0.42 | 0.82 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(39.62%) | (9.15%) | (2.81%) | (20.30%) | (3.77%) | (2.26%) | (6.94%) | (7.86%) | (46.99%) | (7.27%) |
Free Cash Flow Yield |
(29.44%) | (9.45%) | (2.22%) | (12.66%) | (4.02%) | (1.98%) | (6.25%) | (7.51%) | (15.37%) | (85.00%) |
Revenue per Share |
3.26 | 3.58 | 3.26 | 2.85 | 3.07 | 2.92 | 2.26 | 1.71 | 6.09 | 8.21 |
Operating CF per Share |
(1.81) | (0.92) | (0.50) | (1.31) | (1.32) | (0.79) | (1.04) | (1.31) | (5.88) | (8.28) |
Capex per Share |
(0.06) | (0.09) | (0.10) | (0.31) | (0.38) | (0.13) | (0.43) | (0.07) | (0.30) | (0.25) |
Free Cash Flow per Share |
(1.87) | (1.00) | (0.60) | (1.63) | (1.70) | (0.92) | (1.48) | (1.37) | (6.19) | (8.52) |
Cash per Share |
2.77 | 7.54 | 8.55 | 9.16 | 11.01 | 6.14 | 4.35 | 2.02 | 21.21 | 13.85 |
Shareholders Equity per Share |
6.94 | 8.60 | 9.31 | 9.68 | 12.25 | 6.97 | 5.13 | 1.87 | 17.53 | 6.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.94 | 8.60 | 9.31 | 9.68 | 12.25 | 6.97 | 5.13 | 1.87 | 17.53 | 6.29 |
Free Cash Flow |
(79.85) | (38.53) | (22.69) | (60.22) | (61.30) | (27.29) | (37.03) | (30.22) | (23.24) | (18.27) |
Working Capital |
137.50 | 321.59 | 343.11 | 350.18 | 411.98 | 179.80 | 112.83 | 41.37 | 69.54 | 24.29 |
Capital Expenditures |
(2.61) | (3.37) | (3.84) | (11.61) | (13.67) | (3.93) | (10.85) | (1.50) | (1.13) | (0.53) |
Net Current Asset Value |
89.22 | 287.10 | 303.49 | 305.87 | 388.38 | 154.69 | 91.37 | 32.95 | 63.34 | 11.60 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.11 | 0.12 | 0.05 | 0.19 | 0.04 | 0.05 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.00 | 0.38 | 0.43 | 0.27 | 0.30 | 0.38 | 0.30 | 0.46 | 0.26 | 0.36 |
Cash ROIC |
(19.29%) | (6.22%) | (3.38%) | (8.64%) | (7.32%) | (6.90%) | (15.09%) | (32.46%) | (15.00%) | (34.22%) |
Accounts Receivable Turnover |
4.47 | 4.78 | 5.51 | 4.93 | 5.40 | 6.15 | 6.41 | 6.07 | 4.81 | 5.69 |
Accounts Payable Turnover |
7.21 | 9.05 | 10.84 | 9.22 | 5.72 | 6.07 | 5.49 | 4.54 | 4.22 | 5.05 |
Inventory Turnover |
1.69 | 1.84 | 2.23 | 3.07 | 2.47 | 3.02 | 3.64 | 4.14 | 5.05 | 7.78 |
Average Days of Payables |
66.98 | 46.72 | 38.27 | 23.27 | 73.42 | 64.97 | 70.53 | 94.75 | 100.60 | 94.58 |
Days of Inventory on Hand |
270.34 | 220.24 | 198.05 | 102.92 | 176.90 | 141.97 | 127.73 | 110.24 | 101.14 | 56.70 |
Average Receivables |
31.06 | 28.78 | 22.22 | 21.40 | 20.49 | 14.05 | 8.85 | 6.20 | 4.76 | 3.09 |
Average Payables |
10.26 | 6.00 | 4.44 | 6.52 | 8.00 | 6.29 | 5.44 | 4.33 | 3.05 | 1.95 |
Average Inventory |
43.77 | 29.45 | 21.54 | 19.58 | 18.52 | 12.66 | 8.20 | 4.76 | 2.55 | 1.27 |
Average Assets |
412.65 | 417.55 | 431.07 | 467.55 | 386.29 | 220.50 | 118.78 | 79.70 | 64.45 | 22.23 |
Average Common Equity |
312.88 | 340.00 | 353.95 | 399.44 | 323.54 | 167.39 | 84.86 | 53.47 | (24.62) | (101.87) |
Columns are period end dates